Search
-
Exporting Healthcare: a New Phase for Australia, the ‘Lucky Country’
Australia’s economy is in transition. The nation is actively trying to set course for an economy where the relative GDP footprint earned from being the world’s quarry is smaller, replaced all manner of services, knowledge and experiences; mostly exported into emerging Asian countries. We are plotting a plan to be less brawn, more brains. Less soil, more skills.
-
[Webinar] Connected Health: The Physicians' View
On September 6, join us for a webinar where we’ll reveal findings from our 18-country primary care physician study on perceptions of connected health.
-
Ipsos Healthcare adds Hidradenitis Suppurativa (HS) to Global Therapy Monitor Portfolio
Ipsos Healthcare, the global healthcare division of Ipsos, has launched the Hidradenitis Suppurativa (HS) Therapy Monitor in the EU5. The HS Monitor, part of Ipsos’ Autoimmune Real World Evidence portfolio, launched in the EU5 in Q2 of 2017, with plans to extend to other markets.
-
Identifying opportunities within Asean’s universal healthcare programmes
The strong growth potential of emerging economies, such as those within the Association of Southeast Asian Nations (ASEAN), continues to attract attention from global businesses.
-
Conquering Complexity: The coming revolution in oncology biomarker testing
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
-
[EVENT] ASCO Annual Meeting
On June 2, join Ipsos Healthcare’s Marco Dibonaventura who will be presenting at this year’s conference dedicated to the brightest minds of oncology.
-
Ipsos Healthcare Expands Syndicated Real World Evidence Offer in China
Ipsos Healthcare has extended its syndicated Psoriasis and IBD Therapy Monitors into China. It will also re-launch the Lupus Therapy Monitor in China due to increased client demand
-
[EVENT] ISPOR 22nd Annual Meeting 2017
On May 20, please join the Ipsos Healthcare team who’ll be presenting data on key topics in NASH, Oncology, Diabetes and Obesity, as well as exhibiting at the 22nd International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting.
-
Understanding Society - A Healthy Understanding?
This international report looks at attitudes towards health over a wide range of issues.
-
Ipsos Launches Syndicated Social Listening in Healthcare
Deployed successfully, social listening can accelerate insight generation from any kind of text data: web forums, social media sites, survey verbatims, internal data, and much more.